enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. JakafiĀ® (ruxolitinib) Prescribing Information Updated with ...

    www.aol.com/news/2013-06-12-jakafi-ruxolitinib...

    The prescribing information for Jakafi now includes a new recommended starting dose of 5 mg twice daily of Jakafi for patients with baseline platelet counts between 50-100 x 10 9 /L (50,000 to ...

  3. Ruxolitinib - Wikipedia

    en.wikipedia.org/wiki/Ruxolitinib

    Ruxolitinib (sold under the brand names Jakafi and Jakavi among others, and as Opzelura in cream form) is a medication used for the treatment of intermediate or high-risk myelofibrosis, [6] a type of myeloproliferative neoplasm that affects the bone marrow; [11] [12] polycythemia vera, when there has been an inadequate response to or intolerance of hydroxyurea; [6] [13] and steroid-refractory ...

  4. Jakafi - Wikipedia

    en.wikipedia.org/?title=Jakafi&redirect=no

    From or to a drug trade name: This is a redirect from (or to) the trade name of a drug to (or from) the international nonproprietary name (INN).

  5. General Code of Operating Rules - Wikipedia

    en.wikipedia.org/wiki/General_Code_of_Operating...

    The GCOR is supplemented by System Special Instructions, Timetables, Hazardous Materials Instructions, Air Brake and Train Handling Instructions, and General Orders. These documents are issued by each individual railroad. System Special instructions, Timetables, and General Order can modify or amend the General Code of Operating Rules. GCOR 1.3 ...

  6. FDA approves Incyte's treatment for chronic graft-versus-host ...

    www.aol.com/news/fda-approves-incytes-treatment...

    Jakafi is approved in the U.S. for treating acute GvHD and is considered a remedy for certain bone marrow and blood d FDA approves Incyte's treatment for chronic graft-versus-host disease Skip to ...

  7. Janus kinase inhibitor - Wikipedia

    en.wikipedia.org/wiki/Janus_kinase_inhibitor

    A Janus kinase inhibitor, also known as JAK inhibitor or jakinib, [1] is a type of immune modulating medication, which inhibits the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway in lymphocytes.

  8. Manual handling of loads - Wikipedia

    en.wikipedia.org/wiki/Manual_handling_of_loads

    To better understand the potential injuries of manual handling of materials, we must first understand the underlying conditions which can cause the injuries. When an injury occurs from manual handling of materials, it often is a result of one of the following underlying condition(s). Awkward posture: Bending or twisting

  9. JAK-STAT signaling pathway - Wikipedia

    en.wikipedia.org/wiki/JAK-STAT_signaling_pathway

    The JAK-STAT signaling pathway is a chain of interactions between proteins in a cell, and is involved in processes such as immunity, cell division, cell death, and tumor formation.